Commit To Purchase Catalyst Pharmaceuticals At $2.50, Earn 42.1% Annualized Using Options
April 18, 2018 at 11:53 AM EDT
Investors considering a purchase of Catalyst Pharmaceuticals Inc (CPRX) shares, but tentative about paying the going market price of $2.60/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $2.50 strike, which has a bid at the time of this writing of 45 cents..